Francesca Casalini - Concepedia

Author

Francesca Casalini

Also Known As

Casalini Francesca, Casalini, Francesca, F Casalini, F. CASALINI, F. Casalini, Francesca CASALINI, Francesca Casalini, OECD

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

University of Pisa University of Naples Federico II Bracco (Italy)Bocconi University Imperial College London

About

Francesca Casalini is an author at University of Pisa specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	465
2	Business	3	3	46
3	Engineering	3	3	98
4	Natural Sciences	3	3	117
5	Public Health	1	1	11

Francesca Casalini

Publications

542

Citations

H-Index

Page 1

	Year	Citations
General medical conditions in 347 bipolar disorder patients: Clinical correlates of metabolic and autoimmune-allergic diseases Giulio Perugi, Giuseppe Quaranta, S Belletti, Journal of Affective Disorders Autoimmune DiseasePsychiatryAllergyMood SymptomDepression	2014	100
<i>N-O-</i>Isopropyl Sulfonamido-Based Hydroxamates: Design, Synthesis and Biological Evaluation of Selective Matrix Metalloproteinase-13 Inhibitors as Potential Therapeutic Agents for Osteoarthritis Elisa Nuti, Francesca Casalini, Stanislava I. Avramova, Journal of Medicinal Chemistry Tissue EngineeringPharmaceutical ScienceSclerostinEngineeringMmp-13 Synthetic Inhibitors	2009	59
Inhibition of metalloproteinases derived from tumours: new insights in the treatment of human glioblastoma P Gabelloni, Eleonora Da Pozzo, S Bendinelli, Neuroscience Neuro-oncologyMedicineMetalloproteinTumor TargetingNew Insights	2010	55
Design, Synthesis, Biological Evaluation, and NMR Studies of a New Series of Arylsulfones As Selective and Potent Matrix Metalloproteinase-12 Inhibitors Elisa Nuti, Laura Panelli, Francesca Casalini, Journal of Medicinal Chemistry ImmunologyNew SeriesNmr StudiesMmp-12 Catalytic DomainChemical Biology	2009	52
Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: Synthesis and biological evaluation Elisa Nuti, Salvatore Santamaria, Francesca Casalini, European Journal of Medicinal Chemistry Medicinal ChemistryPharmaceutical ChemistryPotential Therapeutic AgentsPharmaceutical ScienceAnti-inflammatory	2013	41
Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors Elisa Nuti, Francesca Casalini, Salvatore Santamaria, European Journal of Medicinal Chemistry Medicinal ChemistryMedicineDrug DiscoverySulfonamido-based HydroxamatesNatural Sciences	2011	37
Potent Arylsulfonamide Inhibitors of Tumor Necrosis Factor-α Converting Enzyme Able to Reduce Activated Leukocyte Cell Adhesion Molecule Shedding in Cancer Cell Models Elisa Nuti, Francesca Casalini, Stanislava I. Avramova, Journal of Medicinal Chemistry Cell AdhesionImmunologyTumor BiologyInflammationMolecular Pharmacology	2010	34
Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: A first round of lead optimization Valeria La Pietra, Luciana Marinelli, Sandro Cosconati, European Journal of Medicinal Chemistry Molecular DockingNovel Molecular ScaffoldsMedicinal ChemistryBiochemistryMmp-13 Inhibitors	2011	28
Selective Arylsulfonamide Inhibitors of ADAM-17: Hit Optimization and Activity in Ovarian Cancer Cell Models Elisa Nuti, Francesca Casalini, Salvatore Santamaria, Journal of Medicinal Chemistry Medicinal ChemistryPolymer-drug ConjugateEpithelial Ovarian CancerMedicineRational Drug Design	2013	25
Unplanned readmissions within 30 days after discharge: improving quality through easy prediction Francesca Casalini, S. Salvetti, Silvia Memmini, International Journal for Quality in Health Care	2017	21

Page 1